Blocking of NGF with anti-NGF antibodies or small interfering RNA against NGF inhibited tumor growth and metastasis[6] and inhibitors for TrkA or p75NTR, downstream signaling targets of NGF, also had pro-apoptotic and anti-proliferative effects on BRCA cells[8]. The gene discussed is NTRK1; the disease is neoplasm.